The association of β-arrestin2 polymorphisms with response to antidepressant treatment in depressed patients

被引：7
|
作者：
Petit, Anne-Cecile [1 ,2 ]
El Asmar, Khalil [1 ]
David, Denis J. [3 ]
Gardier, Alain M. [3 ]
Becquemont, Laurent [1 ,4 ]
Feve, Bruno [5 ,6 ,7 ]
Verstuyft, Celine [1 ,8 ,9 ]
Corruble, Emmanuelle [1 ,2 ]
机构：
[1] Univ Paris Sud, INSERM, CESP UMR S1178, Equipe Depress & Antidepresseurs,Fac Med, Le Kremlin Bicetre, France
[2] Hop Bicetre, AP HP, Serv Psychiat, Le Kremlin Bicetre, France
[3] Univ Paris Sud, Univ Paris Saclay, CESP UMR S1178, Equipe Depress & Antidepresseurs,Fac Pharm,INSERM, F-92296 Chatenay Malabry, France
[4] Ctr Rech Clin Paris Sud, AP HP, Le Kremlin Bicetre, France
[5] Pierre & Marie Curie Univ Paris 6, Sorbonne Univ, St Antoine Hosp, INSERM,St Antoine Res Ctr, Paris, France
[6] Hosp Univ Inst, ICAN, Paris, France
[7] St Antoine Hosp, AP HP, Dept Endocrinol, Paris, France
[8] AP HP, Serv Genet Mol Pharmacogenet & Hormonol, Le Kremlin Bicetre, France
[9] Hop Bicetre, AP HP, Ctr Ressources Biol Paris Sud, Le Kremlin Bicetre, France
来源：
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY | 2018年 / 81卷
关键词：
Pharmacogenetics; Antidepressant; Major depressive disorder; Beta-arrestin; ARRB2; BETA-ARRESTINS; DEPENDENCE; LEUKOCYTES; RECEPTORS; PATHWAYS; DISORDER; BRAIN; CELLS; MODEL; GENE;
D O I：
10.1016/j.pnpbp.2017.10.006
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
The study of genetic polymorphisms involved in antidepressants (AD) response is essential to provide a personalized medicine approach in the field of depression. beta-arrestin 2 (ARRB2) is a candidate gene in the pharmacogenetics of AD as it is involved in the signaling cascade downstream of numerous neurotransmitter receptors. We investigated the association between five ARRB2 single nucleotide polymorphisms (SNPs): rs1045280, rs2036657, rs4790694, rs3786047 and rs452246, and response to AD treatment in a sample of 569 patients with a major depressive episode treated for 6 months. We show that GG/GT patients for rs4522461 (n = 534) and AA/AC patients for rs4790694 (n = 244) have a lower response to AD than other genotype groups (HDRS score of 10.9 vs 8.0 after 6 months, multivariate analysis: p = 0.03; 12.2 vs 9.6, p = 0.02, respectively). These data provide additional evidence that beta-arrestin 2 is a regulator of intracellular signal transduction processes involved in AD treatment.
引用
收藏
页码：74 / 79
页数：6
相关论文
共 50 条
  • [41] No impact of eight NTRK2 genetic polymorphisms on 6-month antidepressant efficacy in depressed patients
    Deflesselle, Eric
    Verstuyft, Celine
    Petit, Anne-Cecile
    Hardy, Patrick
    David, Denis J.
    Falissard, Bruno
    Feve, Bruno
    Rigal, Laurent
    Becquemont, Laurent
    Corruble, Emmanuelle
    Colle, Romain
    PHARMACOGENOMICS, 2017, 18 (04) : 349 - 357
  • [42] CYP1A2 genetic polymorphisms are associated with treatment response to the antidepressant paroxetine
    Lin, Keh-Ming
    Tsou, Hsiao-Hui
    Tsai, I-Ju
    Hsiao, Mei-Chun
    Hsiao, Chin-Fu
    Liu, Chia-Yih
    Shen, Winston W.
    Tang, Hwa-Sheng
    Fang, Chun-Kai
    Wu, Chi-Shin
    Lu, Shao-Chun
    Kuo, Hsiang-Wei
    Liu, Shi Chih
    Chan, Hsiu-Wen
    Hsu, Ya-Ting
    Tian, Jia-Ni
    Liu, Yu-Li
    PHARMACOGENOMICS, 2010, 11 (11) : 1535 - 1543
  • [43] Diurnal regulation in depressed patients in response to antidepressant therapy as measured by actigraphy
    Dawson, J
    Hindmarch, I
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S182 - S182
  • [44] Targeting β-arrestin2 in the treatment of L-DOPA-induced dyskinesia in Parkinson's disease
    Urs, Nikhil M.
    Bido, Simone
    Peterson, Sean M.
    Daigle, Tanya L.
    Bass, Caroline E.
    Gainetdinov, Raul R.
    Bezard, Erwan
    Caron, Marc G.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2015, 112 (19) : E2517 - E2526
  • [45] β-arrestin2 is indispensable for the antidepressant effects of fluoxetine via inhibiting astrocytic pyroptosis in chronic mild stress mouse model for depression
    Sun, Yiming
    Cai, Hui
    Yang, Daofeng
    Yu, Nengyi
    Sun, Lejie
    Xu, Jingxuan
    Yuan, Hongwei
    Yang, Rong
    Song, Lele
    Liu, Hao
    Ma, Chengyao
    Liu, Zhe
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2024, 976
  • [46] Blood microRNA longitudinal changes in depressed patients during antidepressant treatment
    Maffioletti, E.
    Bettinsoli, P.
    Giovannini, C.
    Bignotti, S.
    Tardito, D.
    Corrada, D.
    Milanesi, L.
    Gennarelli, M.
    Bocchio-Chiavetto, L.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2012, 15 : 150 - 150
  • [47] Tryptophan and serotonin in blood and platelets of depressed patients:: Effect of an antidepressant treatment
    Moreno, Julia
    Campos, Maria G.
    Lara, Carmen
    Lopez, Guadalupe
    Pavon, Lenin
    Hernandez, Ma Eugenia
    Senties, Hector
    Gonzalez-Olvera, Jorge
    Torruco, Mario
    Arango, Ivan
    Heinze, Gerardo
    Torner, Carlos
    SALUD MENTAL, 2006, 29 (04) : 1 - 8
  • [48] Stability of frontal alpha asymmetry in depressed patients during antidepressant treatment
    van der Vinne, Nikita
    Vollebregt, Madelon A.
    van Putten, Michel J. A. M.
    Arns, Martijn
    NEUROIMAGE-CLINICAL, 2019, 24
  • [49] Antidepressant treatment for chronic depressed patients should not be discontinued prior to anesthesia
    Kudoh, A
    Katagai, H
    Takazawa, T
    CANADIAN JOURNAL OF ANAESTHESIA-JOURNAL CANADIEN D ANESTHESIE, 2002, 49 (02): : 132 - 136
  • [50] Efficacy of venlafaxine in depressed patients after failure with prior antidepressant treatment
    De Clercq, M
    Mignon, A
    EUROPEAN PSYCHIATRY, 2000, 15 : 331S - 331S
12345